We are live on
!
Find out more
AAM
Alpine Associates Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
97.55%
This Fund
S&P 500
This Quarter
Est. Return
+5.69%
1 Year Est. Return
+97.55%
3 Year Est. Return
+368.61%
5 Year Est. Return
+1,313.28%
10 Year Est. Return
+23,749.22%
AUM
$2.18B
AUM Growth
+$91.8M
(+4.4%)
Cap. Flow
+$56.7M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
57.23%
Holding
63
New
20
Increased
23
Reduced
5
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPR
Spirit AeroSystems
SPR
|
+$81.5M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$53.1M |
| 3 |
ENV
ENVESTNET, INC.
ENV
|
+$25.1M |
| 4 |
INST
Instructure Holdings, Inc.
INST
|
+$25M |
| 5 |
Bally's
BALY
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$96.2M |
| 2 |
McGrath RentCorp
MGRC
|
+$75.7M |
| 3 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
+$66.4M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$48.9M |
| 5 |
AMED
Amedisys
AMED
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.28% |
| 2 | Healthcare | 18.58% |
| 3 | Energy | 14.36% |
| 4 | Industrials | 13.66% |
| 5 | Financials | 6.77% |
Similar funds
RSCM
SGI
WAS
ACM
BCM
ISS
PP
FDP
Alpine Associates Management's Q3 2024 Portfolio in Review
As of Q3 2024, Alpine Associates Management held 63 positions worth $2.18B, up 4.4% from $2.09B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Alpine Associates Management's Q3 2024 filing shows 20 new, 23 increased, 5 reduced and 14 closed positions. Its largest new stake was Spirit AeroSystems: 2,377,600 shares worth $77.3M. The largest sale was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $96.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
- Alpine Associates Management's largest Q3 2024 buy was Spirit AeroSystems: 2,377,600 shares worth $77.3M.
- Alpine Associates Management added most to Stericycle Inc in Q3 2024, an estimated $53.1M increase.
- Alpine Associates Management's biggest Q3 2024 reduction was Amedisys, cutting an estimated $41M.
- Alpine Associates Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $96.2M.
- Alpine Associates Management's ten largest holdings make up 57% of its $2.18B portfolio in Q3 2024.
- Alpine Associates Management opened 20 new positions and closed 14 in Q3 2024.
- Alpine Associates Management's portfolio value rose 4.4% quarter-over-quarter to $2.18B.
Based on Alpine Associates Management's 13F filing for Q3 2024, filed 8 Nov 2024.